IRIS
METRA, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 24.801
NA - Nord America 10.485
AS - Asia 8.856
Continente sconosciuto - Info sul continente non disponibili 3.005
SA - Sud America 657
AF - Africa 174
OC - Oceania 22
Totale 48.000
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 17.814
US - Stati Uniti d'America 9.675
IT - Italia 3.805
CN - Cina 2.776
SG - Singapore 2.773
FR - Francia 2.202
BD - Bangladesh 1.197
HK - Hong Kong 697
VN - Vietnam 642
BR - Brasile 395
CA - Canada 365
GB - Regno Unito 232
IN - India 216
DE - Germania 199
NL - Olanda 121
JM - Giamaica 96
MX - Messico 89
AR - Argentina 81
IQ - Iraq 72
CR - Costa Rica 71
SE - Svezia 67
FI - Finlandia 56
ES - Italia 53
JP - Giappone 53
TR - Turchia 51
ZA - Sudafrica 51
ID - Indonesia 47
PL - Polonia 47
HN - Honduras 46
CO - Colombia 44
PH - Filippine 41
PK - Pakistan 38
EC - Ecuador 37
SA - Arabia Saudita 37
VE - Venezuela 37
MY - Malesia 35
AT - Austria 30
DZ - Algeria 24
MD - Moldavia 24
CL - Cile 23
NI - Nicaragua 23
TT - Trinidad e Tobago 23
SV - El Salvador 22
TH - Thailandia 21
RO - Romania 20
UA - Ucraina 19
EG - Egitto 18
NP - Nepal 18
GT - Guatemala 17
JO - Giordania 17
PR - Porto Rico 17
MA - Marocco 16
AE - Emirati Arabi Uniti 15
AU - Australia 15
CH - Svizzera 15
KE - Kenya 15
UZ - Uzbekistan 15
LT - Lituania 14
PY - Paraguay 14
TN - Tunisia 13
KR - Corea 12
PT - Portogallo 12
IL - Israele 11
NG - Nigeria 10
PE - Perù 10
RS - Serbia 10
BE - Belgio 9
GR - Grecia 9
IR - Iran 9
DO - Repubblica Dominicana 7
TW - Taiwan 7
AZ - Azerbaigian 6
BO - Bolivia 6
CY - Cipro 6
IE - Irlanda 6
SC - Seychelles 6
UY - Uruguay 6
BA - Bosnia-Erzegovina 5
BY - Bielorussia 5
FJ - Figi 5
OM - Oman 5
SI - Slovenia 5
BB - Barbados 4
BS - Bahamas 4
ET - Etiopia 4
LB - Libano 4
MM - Myanmar 4
SY - Repubblica araba siriana 4
AG - Antigua e Barbuda 3
BZ - Belize 3
CZ - Repubblica Ceca 3
HR - Croazia 3
HU - Ungheria 3
KG - Kirghizistan 3
KW - Kuwait 3
KY - Cayman, isole 3
KZ - Kazakistan 3
LI - Liechtenstein 3
MV - Maldive 3
SN - Senegal 3
Totale 44.933
Salva come PNG Salva come JPEG
Città #
Moscow 4.053
Council Bluffs 2.599
Lauterbourg 1.752
Ashburn 1.176
San Jose 850
Milan 792
Singapore 787
Hong Kong 681
New York 659
Santa Clara 396
Beijing 378
Rome 373
Los Angeles 250
Ho Chi Minh City 206
Orem 181
Dallas 171
Naples 166
Hanoi 155
Bologna 142
Omaha 133
Turin 117
Brescia 90
Catania 86
Buffalo 84
Chennai 78
Bari 69
Figino 69
Toronto 69
Chicago 66
Frankfurt am Main 65
Genoa 59
Atlanta 58
Shanghai 58
Nuremberg 57
Palermo 56
San José 55
Montreal 54
Brooklyn 52
Kingston 51
London 50
Da Nang 47
Las Vegas 46
Miami 45
Florence 44
Phoenix 43
São Paulo 43
Mexico City 42
Manchester 41
Denver 40
Mumbai 40
Tokyo 40
Hefei 38
Houston 38
Lappeenranta 36
Boardman 31
Seattle 31
The Bronx 31
Paris 30
Philadelphia 30
Verona 29
Amsterdam 28
Baghdad 28
Charlotte 28
Haiphong 28
Warsaw 28
Padua 27
Johannesburg 26
San Francisco 25
Hangzhou 23
Managua 22
Pasadena 22
Cagliari 20
Detroit 20
Modena 20
San Salvador 20
Guangzhou 19
Parma 18
Pottstown 18
Princeton 18
Tegucigalpa 18
Brugherio 17
Helsinki 17
Lawrence 17
Queens 17
Stockholm 17
Tampa 17
Venice 17
Amman 16
Kuala Lumpur 16
Perugia 16
Poplar 16
Washington 16
Appleton 15
Baltimore 15
Sacramento 15
Boston 14
Cincinnati 14
Erbil 14
Lahore 14
Quito 14
Totale 18.778
Salva come PNG Salva come JPEG
Nome #
Transcatheter Valve Repair in Heart Failure with Moderate to Severe Mitral Regurgitation 197
Changes in Right Ventricular-to-Pulmonary Artery Coupling After Transcatheter Edge-to-Edge Repair in Secondary Mitral Regurgitation 184
2-year outcomes of MitraClip as a bridge to heart transplantation: The international MitraBridge registry 166
Global epidemiology of heart failure 166
Impact of heart failure severity on the mortality benefit of mitral transcatheter edge-to-edge valve repair 156
Recommendations on pre-hospital and early hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergency Medicine--short version 119
H2FPEF and HFA-PEFF scores performance and the additional value of cardiac structure and function in patients with atrial fibrillation 117
ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up 104
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial 100
Effect of Chronic Kidney Disease on 5-Year Outcome in Patients With Heart Failure and Secondary Mitral Regurgitation Undergoing Percutaneous MitraClip Insertion 99
The effect of sodium-glucose cotransporter 2 inhibitors on left cardiac remodelling in heart failure with reduced ejection fraction: Systematic review and meta-analysis 97
Prognostic value of right ventricular longitudinal strain in patients with secondary mitral regurgitation undergoing transcatheter edge-to-edge mitral valve repair 96
2024 update in heart failure 95
Prognostic Value of Pre-operative Atrial Fibrillation in Patients with Secondary Mitral Regurgitation Undergoing MitraClip Implantation 95
Incidence, Predictors, and Prognostic Impact of New Permanent Pacemaker Implantation After TAVR With Self-Expanding Valves 91
MitraClip in secondary mitral regurgitation as a bridge to heart transplantation: 1-year outcomes from the International MitraBridge Registry 91
Transcatheter Edge-To-Edge Repair in COAPT-ineligible Patients: Incidence and Predictors of 2-year Good Outcome 90
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 87
Long-Term Outcomes After Edge-to-Edge Repair of Secondary Mitral Regurgitation: 5-Year Results From the EuroSMR Registry 86
Artificial intelligence-derived risk score for mortality in secondary mitral regurgitation treated by transcatheter edge-to-edge repair: the EuroSMR risk score 85
Impact of mitral regurgitation in patients with acute heart failure: insights from the RELAX-AHF-2 trial 83
Evolution of tricuspid regurgitation after transcatheter edge-to-edge mitral valve repair for secondary mitral regurgitation and its impact on mortality 82
Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era 82
Concomitant Transcatheter Edge-to-Edge Treatment of Secondary Tricuspid and Mitral Regurgitation: An Expert Opinion 80
Prevalence and outcome of elderly and low-risk patients with degenerative mitral regurgitation undergoing transcatheter edge-to-edge repair 77
Clinical Presentation and Outcome in a Contemporary Cohort of Patients With Acute Myocarditis 75
Assessment of Omecamtiv Mecarbil for the Treatment of Patients With Severe Heart Failure: A Post Hoc Analysis of Data From the GALACTIC-HF Randomized Clinical Trial 74
Atrial Secondary Tricuspid Regurgitation: Insights Into the EuroTR Registry 72
Challenges and future perspectives of transcatheter tricuspid valve interventions: adopt old strategies or adapt to new opportunities? 71
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure Developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC 71
Organ perfusion pressure predicts outcomes in cardiogenic shock patients 68
Derivation and Validation of a Clinical Risk Score for COAPT-Ineligible Patients Who Underwent Transcatheter Edge-to-Edge Repair 67
Percutaneous Edge-to-Edge Mitral Valve Repair: Beyond the Left Heart 66
Lactate Values and Mortality in Patients With Cardiogenic Shock: Insights From the Altshock-2 Registry 66
Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology 66
Dynamic cardiomyoplasty as an effective therapy for dilated cardiomyopathy 66
Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology 65
Performance of risk stratification scores and role of comorbidities in older vs younger patients with pulmonary arterial hypertension 64
Association Between Hemoglobin Levels and Efficacy of Intravenous Ferric Carboxymaltose in Patients With Acute Heart Failure and Iron Deficiency: An AFFIRM-AHF Subgroup Analysis 64
Left atrial disease and left atrial reverse remodelling across different stages of heart failure development and progression: a new target for prevention and treatment 63
Patient phenotype profiling in heart failure with preserved ejection fraction to guide therapeutic decision making. A scientific statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of Hypertension 63
ST-Elevation Myocardial Infarction in Patients With COVID-19: Clinical and Angiographic Outcomes 63
Differences in biomarkers and molecular pathways according to age for patients with HFrEF 62
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis 61
The prognostic value of the Dandel's index in patients undergoing tricuspid transcatheter edge-to-edge repair 61
Worsening of chronic heart failure: definition, epidemiology, management and prevention. A clinical consensus statement by the Heart Failure Association of the European Society of Cardiology 58
Epidemiology, pathophysiology, diagnosis and management of atrial functional mitral regurgitation: An expert opinion paper 58
Moderate Secondary Mitral Regurgitation: Evolving Evidence and Management Strategies 57
TRIVALVE Score: A Risk Score for Mortality/Hospitalization Prediction in Patients Undergoing Transcatheter Tricuspid Valve Intervention 57
Right Ventricular–Pulmonary Artery Coupling in Tricuspid Regurgitation: Prognostic Value and Impact of Treatment Strategy 57
Role of beta1- and alpha2c-adrenergic receptor polymorphisms and their combination in heart failure: a case-control study 56
Prognostic Impact of Heart Failure History in Patients with Secondary Mitral Regurgitation Treated by MitraClip 56
Dietary sodium and fluid intake in heart failure. A clinical consensus statement of the Heart Failure Association of the ESC 56
Centralization of the ST elevation myocardial infarction care network in the Lombardy region during the COVID-19 outbreak 55
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization - the first insight from the AC-TIVE Study 55
Combined evaluation of perfusion and function for the identification of viable myocardium 54
Transcatheter treatment of chronic mitral regurgitation with the MitraClip system: an Italian consensus statement 54
THE INTERPLAY BETWEEN CARDIOLOGY AND DIABETOLOGY: A RENEWED COLLABORATION TO OPTIMIZE CARDIOVASCULAR PREVENTION AND HEART FAILURE MANAGEMENT 54
COVID myocarditis: a review of the literature 53
Management of aortic stenosis and chronic heart failure: A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC 53
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1 - epidemiology, pathophysiology, and diagnosis 53
Pioglitazone improves in vitro viability and function of endothelial progenitor cells from individuals with impaired glucose tolerance 53
The Relevance of Right Ventricular Function and Dimension in Patients Undergoing Transcatheter Tricuspid Edge-to-Edge Repair 52
Left ventricular reverse remodelling predicts long-term outcomes in patients with functional mitral regurgitation undergoing MitraClip therapy: results from a multicentre registry 52
Right heart failure with left ventricular assist devices: Preoperative, perioperative and postoperative management strategies. A clinical consensus statement of the Heart Failure Association (HFA) of the ESC 51
Heart failure with improved versus persistently reduced left ventricular ejection fraction: A comparison of the BIOSTAT-CHF (European) study with the ASIAN-HF registry 51
The role of ventricular–arterial coupling in cardiac disease and heart failure: assessment, clinical implications and therapeutic interventions. A consensus document of the European Society of Cardiology Working Group on Aorta & Peripheral Vascular Diseases, European Association of Cardiovascular Imaging, and Heart Failure Association 51
Blood pressure and intensive treatment up-titration after acute heart failure hospitalization: Insights from the STRONG-HF trial 50
Clinical management and therapeutic optimization of patients with heart failure with reduced ejection fraction and low blood pressure. A clinical consensus statement of the Heart Failure Association (HFA) of the ESC 50
Long-term changes in left ventricular mass, chamber size and function after valve replacement in patients with severe aortic stenosis and depressed ejection fraction 50
Characteristics and outcomes of patients with tricuspid regurgitation and advanced heart failure 49
Knowledge and application of ESC/HFA guidelines in the management of advanced heart failure 49
Mitral regurgitation evolution after transcatheter tricuspid valve interventions - A sub-analysis of the TriValve registry 48
Impact of disproportionate secondary mitral regurgitation in patients undergoing edge-to-edge percutaneous mitral valve repair 48
Effetti cardiovascolari della ventilazione servo-adattativa (ASV) in pazienti affetti da apnee notturne e scompenso cardiaco cronico con disfunzione sistolica ventricolare sinistra 47
Acute Heart Failure: Transitioning From Symptom-Based Care to Remission 47
Decongestion and Outcomes in Patients Hospitalized for Acute Heart Failure: Insights From the RELAX-AHF-2 Trial 47
GLP-1-ra and heart failure-related outcomes in patients with and without history of heart failure: an updated systematic review and meta-analysis 47
Epidemiology, pathophysiology, diagnosis and management of chronic right-sided heart failure and tricuspid regurgitation. A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC 47
[Position paper of the Italian Society of Cardiology: The renin-angiotensin-aldosterone system (RAAS) blockade in heart failure patients - Part I: From RAAS identification to clinical trials] 47
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9) 47
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC 47
Pathophysiological pathways in patients with heart failure and atrial fibrillation 46
Management of cardiac sarcoidosis A clinical consensus statement of the Heart Failure Association, the European Association of Cardiovascular Imaging, the ESC Working Group on Myocardial & Pericardial Diseases, and the European Heart Rhythm Association of the ESC 46
Emicrania, angina e ipertensione arteriosa; dai beta-bloccanti ai calcioantagonisti. La nicardipina 46
Transcatheter Edge-To-Edge Mitral Valve Repair in Non-COAPT-Like Patients: Incidence and Predictors of 2-Year Good Outcome 46
Changes in Liver Function Tests, Congestion, and Prognosis After Acute Heart Failure: The STRONG-HF Trial 46
A roadmap for therapeutic discovery in pulmonary hypertension associated with left heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Pulmonary Circulation & Right Ventricular Function 46
Left Main Spontaneous Coronary Artery Dissection: Clinical Features, Management, and Outcomes 45
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS) 45
Linee guida ESC 2021 per la diagnosi e il trattamento dello scompenso cardiaco acuto e cronico elaborate dalla Task Force per la diagnosi e il trattamento dello scompenso cardiaco acuto e cronico della Società Europea di Cardiologia (ESC) con il contributo straordinario della Heart Failure Association (HFA) dell’ESC 45
Biomarker Profiles of Acute Heart Failure Patients With a Mid-Range Ejection Fraction 45
Neutrophil-to-Lymphocyte Ratio and Outcomes in Patients Admitted for Acute Heart Failure (As Seen in the BLAST-AHF, Pre-RELAX-AHF, and RELAX-AHF Studies) 44
Impact of Pulmonary Hypertension on Outcomes After Transcatheter Tricuspid Valve Edge-to-Edge Repair 44
Burst steroid therapy and quality of life in patients with acute heart failure: Insights from the CORTAHF trial 44
2023 Focused update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 44
Left ventricular ejection fraction digit bias and reclassification of heart failure with mildly reduced vs reduced ejection fraction based on the 2021 definition and classification of heart failure 44
GLP-1 receptor agonists as promising anti-inflammatory agents in heart failure with preserved ejection fraction 44
Amino acids and derivatives, a new treatment of chronic heart failure? 43
[Diagnostic-therapeutic care pathways for patients with cardiac amyloidosis - SIC/ANMCO Consensus document. Edited by the Italian Cardiac Amyloidosis Network (RIAC)] 43
Totale 6.775
Salva come PNG Salva come JPEG
Categoria #
all - tutte 319.322
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 319.322
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202213 0 0 0 3 0 3 2 0 2 0 1 2
2022/2023113 35 16 5 1 3 12 11 12 5 2 2 9
2023/2024134 19 4 12 10 11 13 3 16 0 6 16 24
2024/2025470 42 9 9 19 9 40 57 86 87 51 27 34
2025/202640.787 101 118 119 225 375 5.117 5.418 4.137 18.131 3.540 1.900 1.606
2026/20276.467 2.882 3.585 0 0 0 0 0 0 0 0 0 0
Totale 48.000